Diaphragmatic Myofascial Release for Hyperkyphotic Subjects
ConditionHyperkyphosis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-40
SponsorCairo University
About this trial
kyphotic subjects have respiratory disturbances due to weakening of the diaphragm, responsible for inhalation, which lead to abnormalities in respiratory mechanics and abnormal gas exchange, leading to respiratory complications. Myofascial release of the diaphragm is an intervention intended to indirectly stretch the diaphragm muscle fibers to reduce muscle tension, normalize fiber length, and promote the efficiency of muscle contraction. Although diaphragm myofascial release has been used in clinical practice, to the best of the authors' knowledge, the current study is the first research investigating the effect of diaphragmatic myofascial release on lung function, chest mobility and kyphotic curve in hyperkyphotic subjects.
Eligibility criteria
Qualifiers
The participant's age ranged from 20 to 40 years.
kyphosis angle 40-50◦
reporting pain on palpation of the diaphragm
Disqualifiers
A history of respiratory diseases, heart disease, vascular disease, central nervous system disorder, psychiatric disorders, hypertension.
History of any trauma or fracture to the thoracic spine.
inflammatory diseases such as rheumatoid arthritis, musculoskeletal problem and neurological deficit
Restrictive respiratory disease, smokers.
Trial design
Treatments tested in this trial
- diaphragmatic myofascial release with traditional physical therapy exercises for hyperkyphosis
- traditional physical therapy exercises for hyperkyphosis
Treatment groups
42 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov